Evidence map›Paper›PMID 28412957›Full record

ArticleItalian journal of pediatrics2017

Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit.

A Girardi, S Galletti, E Raschi, A Koci, E Poluzzi, G Faldella, F De Ponti

Open access · goldAbstract readComparative Study
In one paragraph

Article in Italian journal of pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review of Drug Utilization Studies in Neonatal Units: A Global Perspective.International journal of environmental research and public health · 2020
    Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

A GirardiDepartment of Medical and Surgical Sciences, University of Bologna 40138, Bologna, Italy.
S GallettiDepartment of Medical and Surgical Sciences, University of Bologna 40138, Bologna, Italy.
E RaschiDepartment of Medical and Surgical Sciences, University of Bologna 40138, Bologna, Italy.
A KociDepartment of Medical and Surgical Sciences, University of Bologna 40138, Bologna, Italy.
E PoluzziDepartment of Medical and Surgical Sciences, University of Bologna 40138, Bologna, Italy.
G FaldellaDepartment of Medical and Surgical Sciences, University of Bologna 40138, Bologna, Italy.
F De PontiDepartment of Medical and Surgical Sciences, University of Bologna 40138, Bologna, Italy. fabrizio.deponti@unibo.it.ORCID http://orcid.org/0000-0002-0367-9595
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDrug use in preterm neonates admitted to Neonatal Intensive Care Unit (NICU) has been investigated, so far, in terms of unauthorized or off-label use; very little is known on the use of combinations of different active substances, which is frequently required in this population (prophylaxis of infections, treatment of concomitant diseases). The aim of this study was to describe the most common patterns of drug use in an Italian NICU, focusing on those with nephrotoxic potential.

methodsMedical records of preterm neonates (<37 weeks of gestational age) weighing less than 1,500 g at birth and admitted to an Italian NICU were scrutinized in a 3-year retrospective investigation. Analysis included drug exposure, duration of therapies, co-administration of drugs with potential renal side effects; also daily protein supplement was calculated from parenteral nutrition.

resultsA cohort of 159 preterm neonates was selected; 68 were born weighing less than 1,000 g (extremely low birth weight infants, ELBW, Group A), 91 weighed between 1,000 and 1,500 g at birth (Group B). Compared to Group B, neonates of Group A were more likely to receive pharmacological treatments: the most used drugs were antibiotics (especially ampicillin and amikacin, p = .07 and p < .001, respectively), antifungals (especially fluconazole, p < .001), and diuretics (especially furosemide, p < .001). Analysis of co-administration of drugs with potential nephrotoxicity showed ampicillin and amikacin as the most reported combination (94.1% of Group A and 31.9% of Group B), the combination of furosemide with antibacterials (ampicillin or amikacin) was also frequently reported, with average period of combination shorter than 2 days.

conclusionsELBW infants were exposed to a higher number of drugs compared to other neonates and were more likely to receive associations of drugs with nephrotoxic potential (e.g. furosemide and amikacin), though only for short cycles. Further studies should evaluate the safety profile (especially potential renal side effects) related to most commonly used combinations.

Indexed as

Drug UtilizationInfant, PrematureInfant, Very Low Birth WeightAmikacinAmpicillinCohort StudiesCritical CareDrug-Related Side Effects and Adverse ReactionsDrug Therapy, CombinationFemaleFollow-Up StudiesGestational AgeHumansInfant, Extremely Low Birth WeightIntensive Care Units, NeonatalItalyAmikacinAmpicillinPharmaceutical PreparationsDrug useNeonatal intensive care unitNephrotoxicityPreterm neonates

Identifiers

PMID28412957
PMCPMC5392975
OpenAlexW2607473882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.